BG Medicine, Inc.
BGMD, a company focused on the development and commercialization of
novel cardiovascular diagnostics, today announced that it intends to offer and
sell shares of its common stock in an underwritten public offering. BG
Medicine also expects to grant the underwriters a 30-day option to purchase
additional shares of common stock to cover over-allotments, if any. Lazard
Capital Markets LLC is acting as sole book-running manager for the offering.
While the offering is expected to price before 9:30 am EST on January 25,
2013, the offering is subject to market conditions, and there can be no
assurance as to whether or when the offering may be completed, or as to the
actual size or terms of the offering.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in